title: Vioxx, radiology, and the Food and Drug Administration.
authors.affiliation: Department of Radiology, Georgetown University Medical Center, Washington, DC 20007-2197, USA. Michael.J.Pentecost@kp.org
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Pentecost
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D003257:Consumer Product Safety / Q000592:standards*; D018795:Device Approval / Q000592:standards*; D017277:Drug Approval; D004345:Drug Industry / Q000592:standards / Q000639:trends; D004864:Equipment and Supplies / Q000592:standards; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D007883:Legislation, Medical; D011786:Quality Control; D011871:Radiology / Q000295:instrumentation*; D013450:Sulfones / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
chemical_list: D007783:Lactones; D013450:Sulfones; C116926:rofecoxib